TY  - GEN
AU  - Goodkin,D E
AU  - Rudick,R A
AU  - VanderBrug Medendorp,S
AU  - Daughtry,M M
AU  - Schwetz,K M
AU  - Fischer,J
AU  - Van Dyke,C
TI  - Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis
SN  - 0364-5134
PY  - 1995///0207
KW  - Administration, Oral
KW  - Adult
KW  - Chronic Disease
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Immunosuppression Therapy
KW  - Male
KW  - Methotrexate
KW  - administration & dosage
KW  - Middle Aged
KW  - Multiple Sclerosis
KW  - drug therapy
KW  - Treatment Failure
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/ana.410370108
ER  -